C-C2-03: Incidence-based Costs of Multiple HAART Switches Among HIV-infected Patients in an HMO

Background: Highly active antiretroviral therapy (HAART) or combination antiretroviral (ARV) therapy is associated with reduced morbidity and mortality. Yet, many HIV-infected patients endure incomplete HIV suppression from HAART or combination ARV therapy, increasing cost and limiting effectiveness...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Meenan, Richard T, Rosetti, Maureen C O’Keeffe, Kimes, Terry, Leyden, Wendy, Silverberg, Michael J, Antoniskis, Diana, Horberg, Michael A
Formato: Artigo
Idioma:Inglês
Publicado: Marshfield Clinic 2010
Assuntos:
SELECTED ABSTRACTS - HMORN 2009: Health Economics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842333/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.8.1.52
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares